A. Ouzzane

3.9k total citations
67 papers, 2.2k citations indexed

About

A. Ouzzane is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, A. Ouzzane has authored 67 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 26 papers in Surgery and 19 papers in Rheumatology. Recurrent topics in A. Ouzzane's work include Prostate Cancer Diagnosis and Treatment (36 papers), Prostate Cancer Treatment and Research (31 papers) and Bladder and Urothelial Cancer Treatments (22 papers). A. Ouzzane is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (36 papers), Prostate Cancer Treatment and Research (31 papers) and Bladder and Urothelial Cancer Treatments (22 papers). A. Ouzzane collaborates with scholars based in France, United States and Switzerland. A. Ouzzane's co-authors include Arnauld Villers, Pierre Colin, Philippe Puech, Morgan Rouprêt, L. Lemaître, Xavier Leroy, Nacim Betrouni, Georges‐Pascal Haber, Sébastien Crouzet and V. Flamand and has published in prestigious journals such as Cancer, Radiology and The Journal of Urology.

In The Last Decade

A. Ouzzane

66 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Ouzzane France 25 1.3k 1.1k 398 386 283 67 2.2k
Mira Keyes Canada 30 2.0k 1.6× 366 0.3× 239 0.6× 399 1.0× 292 1.0× 116 2.5k
Marco Roscigno Italy 30 1.9k 1.4× 1.6k 1.5× 591 1.5× 271 0.7× 599 2.1× 113 3.0k
Rafael Sanchez‐Salas France 22 1.3k 1.0× 507 0.5× 458 1.2× 149 0.4× 294 1.0× 113 1.8k
Yvonne L. Hoogeveen Netherlands 18 906 0.7× 434 0.4× 265 0.7× 572 1.5× 91 0.3× 33 1.6k
Cathy Corbishley United Kingdom 22 455 0.4× 857 0.8× 631 1.6× 128 0.3× 500 1.8× 55 1.5k
Tim Dudderidge United Kingdom 18 718 0.6× 497 0.5× 254 0.6× 76 0.2× 207 0.7× 58 1.3k
Venu Chalasani Australia 17 734 0.6× 422 0.4× 202 0.5× 232 0.6× 321 1.1× 73 1.3k
Marc Engelbrecht Netherlands 26 1.6k 1.2× 605 0.6× 284 0.7× 1.2k 3.2× 73 0.3× 53 2.4k
Richard P. Meijer Netherlands 21 565 0.4× 1.1k 1.0× 165 0.4× 110 0.3× 349 1.2× 96 1.7k
John E. Sylvester United States 15 1.6k 1.3× 381 0.4× 277 0.7× 219 0.6× 183 0.6× 38 1.9k

Countries citing papers authored by A. Ouzzane

Since Specialization
Citations

This map shows the geographic impact of A. Ouzzane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ouzzane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ouzzane more than expected).

Fields of papers citing papers by A. Ouzzane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ouzzane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ouzzane. The network helps show where A. Ouzzane may publish in the future.

Co-authorship network of co-authors of A. Ouzzane

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ouzzane. A scholar is included among the top collaborators of A. Ouzzane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ouzzane. A. Ouzzane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ploussard, Guillaume, et al.. (2018). Radical prostatectomy for locally advanced and high-risk prostate cancer: A systematic review of the literature. Progrès en Urologie. 28(16). 875–889. 11 indexed citations
2.
Beauval, Jean‐Baptiste, Bastien Cabarrou, Giorgio Gandaglia, et al.. (2017). External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients. The Prostate. 77(8). 928–933. 7 indexed citations
3.
Villers, Arnauld, V. Flamand, Philippe Puech, et al.. (2017). Robot‐assisted partial prostatectomy for anterior prostate cancer: a step‐by‐step guide. British Journal of Urology. 119(6). 968–974. 16 indexed citations
4.
Beauval, Jean‐Baptiste, Guillaume Ploussard, Bastien Cabarrou, et al.. (2016). Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy. World Journal of Urology. 35(8). 1191–1197. 10 indexed citations
6.
Ouzzane, A., et al.. (2015). Understanding the pathological implications of MRI. Current Opinion in Urology. 25(3). 198–204. 7 indexed citations
7.
Puech, Philippe, Arnauld Villers, A. Ouzzane, & L. Lemaître. (2014). Prostate cancer: Diagnosis, parametric imaging and standardized report. Diagnostic and Interventional Imaging. 95(7-8). 743–752. 9 indexed citations
8.
Puech, Philippe, Arnauld Villers, L. Lemaître, et al.. (2014). The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer. World Journal of Urology. 32(4). 951–958. 36 indexed citations
9.
Ouzzane, A., et al.. (2014). A survey of prostate modeling for image analysis. Computers in Biology and Medicine. 53. 190–202. 8 indexed citations
10.
Ouzzane, A., Philippe Puech, & Arnauld Villers. (2014). How accurately can MRI detect indolent disease?. Current Opinion in Urology. 24(3). 264–269. 5 indexed citations
11.
Hurel, S., Morgan Rouprêt, Thomas Seisen, et al.. (2014). Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy. World Journal of Urology. 33(3). 335–341. 37 indexed citations
12.
Rozet, François, François Audenet, A. Ouzzane, et al.. (2013). Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesicle invasion (pT3b) without adjuvant therapy. World Journal of Urology. 32(2). 519–524. 12 indexed citations
13.
Ouzzane, A. & Pierre Colin. (2013). Tumour recurrence after radical nephroureterectomy for UTUC. Nature Reviews Urology. 11(1). 15–16. 6 indexed citations
14.
Colin, Pierre, A. Ouzzane, David Yates, et al.. (2012). Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival. Annals of Surgical Oncology. 19(11). 3613–3620. 57 indexed citations
16.
Villers, Arnauld, et al.. (2012). MRI in addition to or as a substitute for prostate biopsy: The clinician's point of view. Diagnostic and Interventional Imaging. 93(4). 262–267. 19 indexed citations
17.
Colin, Pierre, Philippe Puech, Arnauld Villers, et al.. (2012). Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI. World Journal of Urology. 31(1). 13–19. 25 indexed citations
19.
Ouzzane, A., et al.. (2011). Hématopoïèse extramédullaire rénale. Progrès en Urologie. 21(8). 575–579. 2 indexed citations
20.
Colin, Pierre, Nacim Betrouni, A. Ouzzane, et al.. (2010). Thérapie photodynamique et cancer de la prostate. Progrès en Urologie. 21(2). 85–92. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026